Veraxa Biotech AG
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q2 25 | Q4 25 |
|---|---|---|---|
| – | -3.0% | -1.7% | |
| – | -30.3% | -26.2% | |
| – | -38.2% | -51.3% | |
| – | +0.0% | +0.0% | |
| – | -1.5% | -1.5% | |
| – | +29.4% | +38.9% | |
| – | +30.0% | +99.9% | |
| – | +131.4% | +23.0% | |
| – | -59.0% | -223.9% | |
| – | – | – | |
| – | +0.0% | +0.0% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.